Oncotelic Therapeutics Inc. Insider Trading

OTLC

⊜ Compare

Last 12 months

Insiders bought 61K on the open market and sold nothing.

Net open-market

+61K

5 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Oct 2026

Oct 29, 2026

Get an email when OTLC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 28 – 29	Vuong Trieu Chairman and CEO	Bought 2 parts	1,356,990	$0.02 average	24K	1.2%	Form 4
Jul 1	Vuong Trieu Chairman and CEO	Bought	240,000	$0.04	10K	0.2%	Form 4
Jun 22 – 24	Vuong Trieu Chairman and CEO	Bought 3 parts	255,000	$0.05 average	13K	0.2%	Form 4
Jun 22	Amit B. Shah CFO	Bought	20,000	$0.05	1K	5.6%	Form 4
Jun 15 – 17	Vuong Trieu Chairman and CEO	Bought 2 parts	335,759	$0.04 average	14K	0.3%	Form 4
Jul 8, 2025 – Jul 10, 2025	Vuong Trieu Chairman and CEO	Bought 3 parts	198,737	$0.01 average	2K	0.2%	Form 4
Jan 29, 2025 – Jan 31, 2025	Vuong Trieu Chairman and CEO	Bought 3 parts	346,844	$0.03 average	10K	0.3%	Form 4
Nov 22, 2024	Vuong Trieu Chairman and CEO	Bought	298,499	$0.03	9K	0.3%	Form 4

Oct 28 – 29
Vuong Trieu
Chairman and CEO · bought 1,356,990 at avg $0.02
24K
1.2% of stake
Jul 1
Vuong Trieu
Chairman and CEO · bought 240,000 at $0.04
10K
0.2% of stake
Jun 22 – 24
Vuong Trieu
Chairman and CEO · bought 255,000 at avg $0.05
13K
0.2% of stake
Jun 22
Amit B. Shah
CFO · bought 20,000 at $0.05
1K
5.6% of stake
Jun 15 – 17
Vuong Trieu
Chairman and CEO · bought 335,759 at avg $0.04
14K
0.3% of stake
Jul 8, 2025 – Jul 10, 2025
Vuong Trieu
Chairman and CEO · bought 198,737 at avg $0.01
2K
0.2% of stake
Jan 29, 2025 – Jan 31, 2025
Vuong Trieu
Chairman and CEO · bought 346,844 at avg $0.03
10K
0.3% of stake
Nov 22, 2024
Vuong Trieu
Chairman and CEO · bought 298,499 at $0.03
9K
0.3% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OTLC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with OTLC

CompareIntrinsic value

BNTCBenitec Biopharma Inc.

$9.28+10.48%10

AVTXAvalo Therapeutics Inc.

$7.07-2.48%10

SILOSilo Pharma Inc.

$1.33+3.91%10

OWPCOne World Products Inc.

$0.00+0.00%46

ATNMActinium Pharmaceuticals Inc.

$1.41+0.71%30

AXIMAxim Biotechnologies Inc.

$0.00+6.67%0

LNAILunai Bioworks Inc.

$0.16-30.17%10

ALTAltimmune, Inc.

$2.12+3.92%10

Spot a number that looks wrong? Check it in OTLC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OTLC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.